Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

9

Revenue 2017

Lantus

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lantus was produced by Sanofi.

Could formulary intelligence be your brand differentiator?

Abasaglar – a biosimilar to Lantus (diabetes), offering a money-saving value proposition for medicines management. ... Toujeo – a long-acting insulin injection (diabetes) and heir to Sanofi’s #1 insulin brand Lantus.

20 for 2020 – Five pharma leaders to watch in 2020

20 for 2020 – Five pharma leaders to watch in 2020 protection for Lantus (insulin glargine) – as well as cardiovascular disease research.

Sanofi narrows focus, shedding diabetes and cardiovascular research

Sanofi narrows focus, shedding diabetes and cardiovascular research year. Its insulin Lantus was the top selling product across its diabetes business, bringing in 751m, a drop of almost 17.5% from the same period last year.

Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn

Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn Sanofi has had a challenging few years following the loss of patent protection for its former diabetes cash cow Lantus (insulin glargine), with some pipeline successes – notably atopic dermatitis and asthma

Sanofi said to be looking at options for $30bn consumer health unit

Sanofi said to be looking at options for $30bn consumer health unit Sanofi has had a difficult few years following the loss of patent protection for its former diabetes cash cow Lantus (insulin glargine), with some pipeline successes – notably atopic dermatitis and asthma

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....